BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22075446)

  • 1. The evolution of cefotaximase activity in the TEM β-lactamase.
    Singh MK; Dominy BN
    J Mol Biol; 2012 Jan; 415(1):205-20. PubMed ID: 22075446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
    Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
    J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
    Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X; Minasov G; Shoichet BK
    Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
    J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of an extended-spectrum class A beta-lactamase from Proteus vulgaris K1.
    Nukaga M; Mayama K; Crichlow GV; Knox JR
    J Mol Biol; 2002 Mar; 317(1):109-17. PubMed ID: 11916382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate.
    Perilli M; Mugnaioli C; Luzzaro F; Fiore M; Stefani S; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1564-6. PubMed ID: 15793140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural effects of the active site mutation cysteine to serine in Bacillus cereus zinc-beta-lactamase.
    Chantalat L; Duée E; Galleni M; Frère JM; Dideberg O
    Protein Sci; 2000 Jul; 9(7):1402-6. PubMed ID: 10933508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of PBP-A from Thermosynechococcus elongatus, a penicillin-binding protein closely related to class A beta-lactamases.
    Urbach C; Evrard C; Pudzaitis V; Fastrez J; Soumillion P; Declercq JP
    J Mol Biol; 2009 Feb; 386(1):109-20. PubMed ID: 19100272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases.
    Maveyraud L; Pratt RF; Samama JP
    Biochemistry; 1998 Feb; 37(8):2622-8. PubMed ID: 9485412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance.
    Salverda ML; De Visser JA; Barlow M
    FEMS Microbiol Rev; 2010 Nov; 34(6):1015-36. PubMed ID: 20412308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evolution of new catalytic activity with an existing protein scaffold.
    Park HS; Nam SH; Lee JK; Yoon CN; Mannervik B; Benkovic SJ; Kim HS
    Science; 2006 Jan; 311(5760):535-8. PubMed ID: 16439663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and resistance in TEM beta-lactamase.
    Wang X; Minasov G; Blázquez J; Caselli E; Prati F; Shoichet BK
    Biochemistry; 2003 Jul; 42(28):8434-44. PubMed ID: 12859188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme.
    Stec B; Holtz KM; Wojciechowski CL; Kantrowitz ER
    Acta Crystallogr D Biol Crystallogr; 2005 Aug; 61(Pt 8):1072-9. PubMed ID: 16041072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.